29 results on '"Trefzer, U."'
Search Results
2. Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study
3. Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study
4. Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial
5. Actual practice of melanoma follow-up and treatment in Germany: results of a prospective, longitudinal cohort study
6. Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study
7. SM5-1: a new monoclonal antibody which is highly sensitive and specific for melanocytic lesions
8. Monitoring of circulating tumor cells in a patient with synchronous metastatic melanoma and colon carcinoma
9. Ultra-late recurrence of malignant melanoma after a disease-free interval of 41 years
10. IL-7 mRNA is not overexpressed in mycosis fungoides and pleomorphic T-cell lymphoma and is unlikely to be an autocrine growth factor in vivo
11. Antitumour activity of paclitaxel and interferon-alpha in a case of metastatic eccrine porocarcinoma
12. Cytokines: interleukin and interferon therapy in dermatology
13. Cytokine therapy in dermatology
14. Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study.
15. A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma.
16. Algorithm for detection of small-bowel metastasis in malignant melanoma of the skin.
17. Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma.
18. Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma.
19. The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview.
20. Malignant melanoma arising in a radiotherapy field: report of two cases and review of the literature.
21. Blisters - an unusual effect during radiotherapy.
22. FC13 DERMA Phase III trial of MAGE-A3 immunotherapy as adjuvant treatment in stage III melanoma: MAGE-A3 gene expression frequency and baseline demographics.
23. Interleukin-2-Associated Bullous Drug Dermatosis.
24. FC10 Sorafenib and pegylated interferon alpha 2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial.
25. Sentinel node biopsy needs for a suitable therapeutic management of the cutaneous melanoma.
26. 834 Second-line treatment of disseminated malignant melanoma with Fotemustine.
27. Cancer stem cells in melanoma.
28. PCN140 - Change in Fatigue and Correlations with Clinical Outcome in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib in the Bolt Study.
29. Treatment Planning for Merkel Cell Carcinoma Based on the Relapse Pattern.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.